DK1653923T3 - Oral afleveringssystem omfattende en bivæsket skum - Google Patents

Oral afleveringssystem omfattende en bivæsket skum

Info

Publication number
DK1653923T3
DK1653923T3 DK04767956.8T DK04767956T DK1653923T3 DK 1653923 T3 DK1653923 T3 DK 1653923T3 DK 04767956 T DK04767956 T DK 04767956T DK 1653923 T3 DK1653923 T3 DK 1653923T3
Authority
DK
Denmark
Prior art keywords
weight
delivery system
foam
biliary
oral delivery
Prior art date
Application number
DK04767956.8T
Other languages
Danish (da)
English (en)
Inventor
Monica Dias
Michelle Georgiou
Philip Guffogg
Fraser Steele
Derek Wheeler
William Charman
Christopher Porter
Colin Pouton
Original Assignee
Drug Delivery Solutions Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drug Delivery Solutions Ltd filed Critical Drug Delivery Solutions Ltd
Application granted granted Critical
Publication of DK1653923T3 publication Critical patent/DK1653923T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
DK04767956.8T 2003-07-30 2004-07-30 Oral afleveringssystem omfattende en bivæsket skum DK1653923T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0317869.6A GB0317869D0 (en) 2003-07-30 2003-07-30 Improved drug delivery system
PCT/GB2004/003329 WO2005011628A2 (en) 2003-07-30 2004-07-30 Oral delivery system comprising a biliquid foam

Publications (1)

Publication Number Publication Date
DK1653923T3 true DK1653923T3 (da) 2010-08-09

Family

ID=27799499

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04767956.8T DK1653923T3 (da) 2003-07-30 2004-07-30 Oral afleveringssystem omfattende en bivæsket skum

Country Status (14)

Country Link
US (1) US20060228408A1 (https=)
EP (1) EP1653923B1 (https=)
JP (1) JP4953815B2 (https=)
CN (2) CN1832727A (https=)
AT (1) ATE465715T1 (https=)
AU (1) AU2004261053B2 (https=)
CA (1) CA2533833C (https=)
DE (1) DE602004026879D1 (https=)
DK (1) DK1653923T3 (https=)
ES (1) ES2344898T3 (https=)
GB (1) GB0317869D0 (https=)
RU (1) RU2353350C2 (https=)
WO (1) WO2005011628A2 (https=)
ZA (1) ZA200600761B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0404403D0 (en) 2004-02-27 2004-03-31 Disperse Ltd Dispersions
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
GB0712389D0 (en) * 2007-06-26 2007-08-01 Drug Delivery Solutions Ltd A Pharmaceutical composition
CN101780037B (zh) * 2010-02-03 2011-11-16 南昌大学 双嘧达莫自乳化给药系统及其制备方法
GB201006218D0 (en) 2010-04-14 2010-06-02 Ayanda As Composition
HRP20191711T1 (hr) 2011-03-14 2019-12-13 Drug Delivery Solutions Ltd Oftalmološki pripravak
EP2696846B1 (en) * 2011-04-11 2018-01-17 Vitux Group AS Oral pharmaceutical dispersion compositions
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486333A (en) * 1981-04-10 1984-12-04 Felix Sebba Preparation of biliquid foam compositions
US4999198A (en) * 1989-03-23 1991-03-12 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Polyaphrons as a drug delivery system
IL105553A (en) * 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage form comprising a porous network of matrix forming material which disperses rapidly in water
US5840881A (en) * 1992-11-27 1998-11-24 Takeda Chemical Industries, Ltd. Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility
CN1138515C (zh) * 1996-03-08 2004-02-18 迪斯珀斯有限公司 包含一种油基双液体泡沫和一种水凝胶的分散体系
NL1003503C2 (nl) * 1996-07-04 1998-01-07 Negma Steba International Dev Farmaceutische samenstelling voor orale toediening.
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
CN1362873A (zh) * 2000-02-22 2002-08-07 彩色通路公司 胶凝的水溶液美容组合物
GB0214793D0 (en) * 2002-06-26 2002-08-07 Disperse Technologies Plc Biliquid foam entrapment

Also Published As

Publication number Publication date
CN101579311A (zh) 2009-11-18
WO2005011628A2 (en) 2005-02-10
CA2533833C (en) 2013-05-28
AU2004261053A1 (en) 2005-02-10
DE602004026879D1 (de) 2010-06-10
CA2533833A1 (en) 2005-02-10
ZA200600761B (en) 2007-05-30
EP1653923B1 (en) 2010-04-28
RU2353350C2 (ru) 2009-04-27
AU2004261053B2 (en) 2011-08-25
ES2344898T3 (es) 2010-09-09
ATE465715T1 (de) 2010-05-15
RU2006106173A (ru) 2007-09-10
JP2007500181A (ja) 2007-01-11
JP4953815B2 (ja) 2012-06-13
EP1653923A2 (en) 2006-05-10
US20060228408A1 (en) 2006-10-12
GB0317869D0 (en) 2003-09-03
CN101579311B (zh) 2013-11-27
WO2005011628A3 (en) 2005-05-06
CN1832727A (zh) 2006-09-13

Similar Documents

Publication Publication Date Title
SG147450A1 (en) Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
WO2007008752A3 (en) Sustained release pharmaceutical compositions for highly water soluble drugs
NO20025621D0 (no) Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser
BR0112311A (pt) Compostos e composições para liberar agentes ativos, forma de dosagem unitária, método para preparar ditas composições e seu uso
WO2007048219A3 (en) Sustained drug release composition
EP1708686A4 (en) GENERAL LINEAR SHELL FORM OF FENTANYL FOR ORAL USE AND METHOD OF ADMINISTRATION
SE0300010D0 (sv) Novel Compounds
PT1401501E (pt) Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo
MY157790A (en) Trazodone composition for once a day administration
WO2001085257A3 (en) Opioid antagonist compositions and dosage forms
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
WO2009028495A1 (ja) 真菌性皮膚炎用剤
WO2008060934A8 (en) Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration
ATE493973T1 (de) Irbesartan enthaltende pharmazeutische zusammensetzung
WO2005112633A3 (en) Compounds and compositions for delivering active agents
AR052252A1 (es) Formulaciones topicas de nepafenac
DK1653923T3 (da) Oral afleveringssystem omfattende en bivæsket skum
MXPA03010054A (es) Composiciones que comprenden lopinavir y metodos para aumentar la biodisponibilidad de agentes farmaceuticos.
WO2004066983A3 (en) Controlled release of highly soluble agents
MY138172A (en) Pharmaceutical compositions based on azetidine derivatives
MXPA03005221A (es) Composicion farmaceutica de dronedarona para administracion parenteral.
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
JP2007500181A5 (https=)
NO20056241L (no) Nanopartikler av polyoksyetylenerte derivater
WO2002034240A3 (en) Delayed and sustained release formulations and method of use thereof